Therapeutic aspects of Sydenham's Chorea: an update.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
21 03 2022
21 03 2022
Historique:
received:
09
12
2021
accepted:
27
01
2022
entrez:
20
4
2022
pubmed:
21
4
2022
medline:
22
4
2022
Statut:
epublish
Résumé
Sydenham's Chorea (SC) is a hyperkinetic movement disorder associated with neuropsychiatric manifestations. It is believed to be caused by the autoimmune response following a group A beta-hemolytic streptococcal (GABHS) pharyngitis, and it is one of the major diagnostic criteria for Acute Rheumatic Fever (ARF) diagnosis. Despite having been known and studied for centuries, there are still no standardized therapies or official guidelines for SC treatment, so that it is necessarily left to physicians' clinical experience. Antibiotic treatment, symptomatic therapies, and immunomodulatory treatment are the three pillars upon which SC patients' management is currently based, but they still lack a solid scientific basis. The aim of this writing is precisely to review the state of the art of SC's treatment, with an overview of the advances made in the last 5 years. However, since the therapeutic uncertainties are a mere reflection of the severe gap of knowledge that concerns SC's pathogenesis and manifestations, the importance of high-quality research studies based on homogenized methodologies, instruments, and measured outcomes will also be stressed.
Identifiants
pubmed: 35441610
doi: 10.23750/abm.v92iS4.12663
pmc: PMC9179053
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2021414Références
Postgrad Med J. 2004 Sep;80(947):527-34
pubmed: 15356354
J Chronic Dis. 1967 Jan;20(1):13-27
pubmed: 6020448
Arch Neurol. 2004 Aug;61(8):1261-4
pubmed: 15313844
BMJ Case Rep. 2016 Feb 01;2016:
pubmed: 26837939
Mov Disord. 2012 Jul;27(8):935-46
pubmed: 22555904
Tremor Other Hyperkinet Mov (N Y). 2017 Jun 1;7:456
pubmed: 28589057
Mov Disord. 2003 Nov;18(11):1374-7
pubmed: 14639684
Curr Treat Options Neurol. 2008 May;10(3):230-5
pubmed: 18579027
Pediatr Neurol. 2006 Apr;34(4):264-9
pubmed: 16638499
Metab Brain Dis. 2016 Feb;31(1):205-12
pubmed: 25987537
Eur J Pediatr. 1993 Aug;152(8):645-6
pubmed: 8404967
Nat Med. 2003 Jul;9(7):914-20
pubmed: 12819778
Eur J Pediatr. 2010 Sep;169(9):1151-4
pubmed: 20349351
Acta Biomed. 2020 Jun 30;91(7-S):5-17
pubmed: 32608372
Br J Clin Pract. 1993 Jan-Feb;47(1):14-6
pubmed: 8461241
Circulation. 2015 May 19;131(20):1806-18
pubmed: 25908771
Dev Med Child Neurol. 2019 Sep;61(9):1101-1107
pubmed: 31175679
Neurology. 2011 Jan 18;76(3):294-300
pubmed: 21242498
Arq Neuropsiquiatr. 2002 Jun;60(2-A):231-3
pubmed: 12068350
J Pediatr. 1972 Dec;81(6):1216-7
pubmed: 4643046
Dev Med Child Neurol. 2017 Feb;59(2):136-144
pubmed: 27900773
eNeurologicalSci. 2018 Nov 27;14:31-33
pubmed: 30555950
J Child Neurol. 2012 Feb;27(2):147-55
pubmed: 21868369
Heliyon. 2019 Nov 26;5(11):e02818
pubmed: 31844735
Lancet. 2018 Jul 14;392(10142):161-174
pubmed: 30025809
Psychiatr Clin North Am. 1997 Dec;20(4):809-20
pubmed: 9443351
Arch Neurol. 1978 Jan;35(1):53-4
pubmed: 202236
Acta Physiol (Oxf). 2016 Jan;216(1):90-100
pubmed: 26454143
Eur J Paediatr Neurol. 2012 Jul;16(4):373-8
pubmed: 22197452
Cureus. 2021 May 12;13(5):e14990
pubmed: 34131535
Acta Biomed. 2020 Jun 30;91(7-S):79-100
pubmed: 32608377
Parkinsonism Relat Disord. 2005 Aug;11(5):327-30
pubmed: 15878690
Acta Biomed. 2020 Jun 30;91(7-S):101-114
pubmed: 32608378
Clin Epidemiol. 2011 Feb 22;3:67-84
pubmed: 21386976
Acta Biomed. 2020 Jun 30;91(7-S):51-60
pubmed: 32608375
Neurosci Behav Physiol. 2009 Sep;39(7):635-8
pubmed: 19621268
J Paediatr Child Health. 2015 Dec;51(12):1235-8
pubmed: 26633611
Neuroradiology. 2003 Jul;45(7):456-62
pubmed: 12811441
Parkinsonism Relat Disord. 2014 Feb;20(2):233-6
pubmed: 24268384
Eur J Paediatr Neurol. 2018 Mar;22(2):327-331
pubmed: 29287833
Mov Disord. 1997 Sep;12(5):701-3
pubmed: 9380051
J Pediatr. 2007 Dec;151(6):679-83
pubmed: 18035153
Medicina (Kaunas). 2020 Apr 24;56(4):
pubmed: 32344710
Biomark Med. 2010 Dec;4(6):871-87
pubmed: 21133708
Acta Biomed. 2020 Jun 30;91(7-S):32-50
pubmed: 32608374
Neurology. 1990 Jan;40(1):186
pubmed: 2296371
Pediatr Neurol. 2000 Aug;23(2):147-51
pubmed: 11020640
Mov Disord. 1999 Sep;14(5):805-7
pubmed: 10495042
Mov Disord. 2010 May 15;25(7):853-7
pubmed: 20461802
Dev Med Child Neurol. 2016 Jan;58(1):16-28
pubmed: 25926089
Pediatr Neurol. 2005 Mar;32(3):205-7
pubmed: 15730904
J Child Neurol. 2005 May;20(5):424-9
pubmed: 15968928
Neurology. 1990 Jul;40(7):1140-1
pubmed: 2113207
Am J Dis Child. 1984 Apr;138(4):341-5
pubmed: 6702784
Neurology. 2002 Jul 23;59(2):227-31
pubmed: 12136062
Parkinsonism Relat Disord. 2007 Jul;13(5):276-83
pubmed: 17240185
Acta Biomed. 2020 Jun 30;91(7-S):18-31
pubmed: 32608373
Acta Biomed. 2020 Jun 30;91(7-S):61-78
pubmed: 32608376
Pediatr Neurol. 2010 Jul;43(1):1-6
pubmed: 20682195
Pediatr Neurol. 1985 Sep-Oct;1(5):317-9
pubmed: 3939747
Pediatr Neurol. 2020 Jan;102:10-19
pubmed: 31604647
N Engl J Med. 1960 Mar 17;262:533-40
pubmed: 13821955
J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1478-9
pubmed: 15377702
Surg Neurol Int. 2018 Jan 25;9:19
pubmed: 29497572
Med J Aust. 1960 Nov 12;47(2):771-4
pubmed: 13768293
J Emerg Med. 2019 Jun;56(6):e119-e121
pubmed: 31003820
J Pediatr. 1976 Feb;88(2):301-3
pubmed: 1249696
Neurology. 1997 Feb;48(2):531-3
pubmed: 9040753
Eur J Paediatr Neurol. 2022 Jan;36:1-6
pubmed: 34768201
Brain Sci. 2021 Mar 18;11(3):
pubmed: 33803885
Expert Rev Neurother. 2021 Aug;21(8):913-922
pubmed: 34353207
J Clin Mov Disord. 2015 Jan 21;2:2
pubmed: 26788338